0.0CHF
619.00 KCHF
212.01 MCHF
4.75 M
About MEDARTIS N
Sector
Industry
CEO
Christoph Brönnimann
Website
Headquarters
Basel
Employees (FY)
876
Founded
1997
ISIN
CH0386200239
FIGI
BBG00K68NZ53
Medartis Holding AG engages in the development, manufacture, and sale of medical devices for surgical fixation of bone fractures. It operates through the following geographical segments: EMEA, US, APAC, and LATAM. The company was founded by Thomas Straumann on November 3, 1997 and is headquartered in Basel, Switzerland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MED is 81.0 CHF — it has decreased by 0.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange MEDARTIS N stocks are traded under the ticker MED.
MED stock is 0.74% volatile and has beta coefficient of 1.73. Check out the list of the most volatile stocks — is MEDARTIS N there?
One year price forecast for MEDARTIS N has a max estimate of 110.0 CHF and a min estimate of 95.5 CHF.
MEDARTIS N revenue for the last quarter amounts to 103.30 M CHF despite the estimated figure of 103.50 M CHF. In the next quarter revenue is expected to reach 108.20 M CHF.
Yes, you can track MEDARTIS N financials in yearly and quarterly reports right on TradingView.
MED stock has fallen by 0.25% compared to the previous week, the month change is a 5.19% rise, over the last year MEDARTIS N has showed a 16.71% increase.
MED net income for the last quarter is 1.47 M CHF, while the quarter before that showed −848.04 K CHF of net income which accounts for 272.99% change. Track more MEDARTIS N financial stats to get the full picture.
Today MEDARTIS N has the market capitalization of 1.10 B, it has increased by 5.51% over the last week.
No, MED doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MED shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDARTIS N stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 876.00 employees. See our rating of the largest employees — is MEDARTIS N on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDARTIS N technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDARTIS N stock shows the buy signal. See more of MEDARTIS N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEDARTIS N future price: according to them, MED price has a max estimate of 110.00 CHF and a min estimate of 95.50 CHF. Read a more detailed MEDARTIS N forecast: see what analysts think of MEDARTIS N and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDARTIS N EBITDA is 32.44 M CHF, and current EBITDA margin is 15.30%. See more stats in MEDARTIS N financial statements.